Nektar Therapeutics | NKTR - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
ALKERMES USD -48.28M 37.33M 2026-03
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Amgen USD 3.83B 130M 2026-03
Baxter International USD 66M 280.2M 2026-03
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
Biogen USD 514.3M 128.8M 2026-03
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Cara Therapeutics USD -5.94M 3.55M 2025-09
Cipla INR 6.14B 3.63B 2026-03
Dr.Reddys Laboratories INR 888M 13.05B 2026-03
Eisai JPY -10.31B 30.35B 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Esperion Therapeutics USD 85.23M 95.19M 2025-12
Exelixis USD 251.34M 15.43M 2026-03
Gilead Sciences USD 2.68B 284M 2026-03
GlaxoSmithKline GBP 2.29B 856M 2026-03
Grifols EUR 320.55M 91.01M 2025-12
Halozyme Therapeutics USD -61.77M 26.64M 2026-03
Incyte USD 324.17M 59.7M 2026-03
Ionis Pharmaceuticals USD -118M 97M 2026-03
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Karyopharm Therapeutics USD -17.84M 13.44M 2025-12
MacroGenics USD -33.44M 21.34M 2026-03
Merck USD -1.88B 8.12B 2026-03
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Neurocrine Biosciences USD 214.6M 13.3M 2026-03
Novartis USD 4.24B 171M 2026-03
Pfizer USD 4.99B 340M 2026-03
Roche Holding CHF 9.56B 3.8B 2025-12
Sarepta Therapeutics USD 358.43M 768.52M 2026-03
Takeda JPY -13.62B 182.44B 2026-03
Teva Pharmaceutical Industries USD 758M 271M 2026-03
Xencor USD -77.86M 24.23M 2026-03